Multiple Sclerosis Clinical Trials

Showing 3961-3980 of 5,960 trials

PROFILE - Evaluation of QoL and PRO Outcomes in Patients Taking Fingolimod

NCT02335892

Multi centre, prospective, non interventional study in 200-240 UK relapsing remitting multiple sclerosis patients. Patients will complete questionnaires at baseline, 3, 6 and 12 months.

Relapsing Remitting Multiple Sclerosis

Novartis Pharmaceuticals114 participantsStarted Nov 2014

Truro, Cornwall, United Kingdom • Swansea, England, United Kingdom • Romford, Essex, United Kingdom +11 more locations

TERMINATEDPhase 1

A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid Tumors

NCT02129205

To assess the safety and tolerability at increasing dose levels of PF-06650808 in patients with advanced solid tumors in order to determine the maximum tolerated dose and select the recommended Phase 2 dose.

NeoplasmsBreast Cancer

Pfizer40 participantsStarted Jun 2014

Los Angeles, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +8 more locations

PROFILE - Evaluation of QoL and PRO Outcomes in Patients Taking Fingolimod

A Dose Escalation Study of PF-06650808 in Patients With Advanced Solid Tumors

Related Searches

Biweekly Avastin and Docetaxel as the First Line Treatment for Patients With Metastatic Breast Cancer

Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL

The Diagnostic Value of 18F-FET PET/MRI for CNS Tumors in Children and Adolescents

Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction

Medication Usage and Patient Reported Outcomes Evaluation Via myBETAapp in Patients With Multiple Sclerosis Treated With Betaferon: a Pilot Study

Pharmacist-led Medicines Management Outpatient Service

Comparing Tolerability and Absorption of Racemic and R-lipoic Acid in Progressive Multiple Sclerosis

Split Renal Function Using 99mTc-DTPA Versus 99mTc-DMSA in Kidney Patients of Wide Age Ranges.

Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving Chemotherapy

Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAPC)

Phase 1/2a DTA-H19 in Patients With Unresectable Pancreatic Cancer

A Randomized Study of Amplimexon (Imexon) With Gemcitabine in Pancreatic Cancer

Radiomics Multifactorial Biomarker for Pulmonary Nodules

Investigating the Effects of Beta-Hydroxy-Beta-Methylbutyrate on Glucose Handling in Older and Younger Men.

A 4-arm Clinical Trial of Fuse®, EndoCuff™, EndoRings™ and Standard Colonoscopy

The Effect of Watching Relaxing Video During Cystoscopy

Work-related Musculoskeletal System Disorders Among Female Workers in Hazelnut Factory

Red Ginseng Extract With Climacteric Symptoms